Leerink upgraded Doximity (DOCS) to Outperform from Market Perform with a price target of $90, up from $60. While “admittedly late on this,” ...

An investment banker who left Goldman Sachs & Co. for Leerink Partners LLC advanced part of her lawsuit saying she was denied promised bonuses and deferred grant awards worth millions of dollars.

Fintel reports that on February 6, 2025, Leerink Partners downgraded their outlook for Hologic (NasdaqGS:HOLX) from Outperform to Market Perform. Analyst Price Forecast Suggests 20.21% Upside As of ...

Rep. Ro Khanna (D-Calif.) joins 'Squawk Box' to discuss President Trump's third week back in office, DOGE and Elon Musk's efforts to downsize the federal government, working across the aisle in the ...

The company built a digital platform for medical professionals that helps carry out telehealth appointments with patients, ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

TD Cowen analyst Ritu Baral maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price target of $35.00.

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research ...

With a volume of 12,212,671, the price of MRK is down -1.44% at $88.38. RSI indicators hint that the underlying stock may be ...

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating ...

Q4 2024 . Management View. Labcorp reported revenue of $3.3 billion for Q4 2024, an increase of 10% year-over-year, with Di ...